perylene has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caetano, W; César, GB; Consolaro, MEL; Damke, E; Damke, GM; De Souza, MVF; Gonçalves, RS; Mari, NL; Meirelles, LEF; Shinobu-Mesquita, CS; Silva, VR | 1 |
| Dong, L; Galanos, N; He, XP; Ji, DK; Li, J; Liu, Y; Vidal, S; Zang, Y | 1 |
2 other study(ies) available for perylene and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Effects of hypericin encapsulated on Pluronic F127 photodynamic therapy against triple negative breast cancer.
Topics: Anthracenes; Humans; Perylene; Photochemotherapy; Poloxamer; Triple Negative Breast Neoplasms | 2022 |
Supramolecular assembly of fluorogenic glyco-dots from perylenediimide-based glycoclusters for targeted imaging of cancer cells.
Topics: Cell Line, Tumor; Fluorescent Dyes; Humans; Imides; Liver Neoplasms; Optical Imaging; Perylene; Triple Negative Breast Neoplasms | 2017 |